| scholarly article | Q13442814 |
| P356 | DOI | 10.1177/1535370213520114 |
| P698 | PubMed publication ID | 24586097 |
| P50 | author | Maria J. Santos | Q51064290 |
| Reinaldo B. Oriá | Q55538695 | ||
| Gerly Brito | Q76392146 | ||
| P2093 | author name string | Davi C Gonçalves | |
| Karoline S Aragão | |||
| Francisco S Silva | |||
| Herene B M Lucena | |||
| Rafael R da Silva | |||
| Rakel C Evangelista | |||
| Renata C Leitão | |||
| P2860 | cites work | Biology of RANK, RANKL, and osteoprotegerin | Q21195419 |
| RANK is essential for osteoclast and lymph node development | Q24598872 | ||
| Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent | Q28191546 | ||
| Resolution of inflammation: a new paradigm for the pathogenesis of periodontal diseases | Q28206660 | ||
| Development of a classification system for periodontal diseases and conditions | Q33906593 | ||
| The epithelial cell rests of Malassez--a role in periodontal regeneration? | Q34545708 | ||
| Differential expression of RANK, RANK-L, and osteoprotegerin by synovial fluid neutrophils from patients with rheumatoid arthritis and by healthy human blood neutrophils | Q35868974 | ||
| TNF-alpha and pathologic bone resorption | Q36291539 | ||
| Functions of RANKL/RANK/OPG in bone modeling and remodeling | Q36700779 | ||
| Tumor necrosis factor antagonist mechanisms of action: a comprehensive review | Q37043901 | ||
| Mechanisms modulating inflammatory osteolysis: a review with insights into therapeutic targets | Q37106639 | ||
| Mapping the pathogenesis of periodontitis: a new look | Q37232614 | ||
| RANK/RANKL: regulators of immune responses and bone physiology | Q37348448 | ||
| Mechanisms and control of pathologic bone loss in periodontitis | Q37733766 | ||
| Photodynamic therapy in the control of oral biofilms | Q37816537 | ||
| Persistent systemic inflammation in unstable angina is largely unrelated to the atherothrombotic burden | Q37865715 | ||
| Biologic therapy in psoriasis: perspectives on associated risks and patient management | Q38020037 | ||
| Dose-specific effects of tumor necrosis factor alpha on osteogenic differentiation of mesenchymal stem cells | Q38331533 | ||
| Chronic low dose tumor necrosis factor-α (TNF) suppresses early bone accrual in young mice by inhibiting osteoblasts without affecting osteoclasts | Q39140938 | ||
| Current status of the host response in chronic marginal periodontitis | Q40316678 | ||
| Reverse signaling through transmembrane TNF confers resistance to lipopolysaccharide in human monocytes and macrophages | Q40875345 | ||
| Inhibitory effect of chlorpromazine on RANKL-induced osteoclastogenesis in mouse bone marrow cells | Q42727306 | ||
| Effects of tumor necrosis factor-alpha inhibitors pentoxifylline and thalidomide on alveolar bone loss in short-term experimental periodontal disease in rats. | Q44801872 | ||
| The role of RANKL (TRANCE/TNFSF11), a tumor necrosis factor family member, in skeletal development: effects of gene knockout and transgenic rescue | Q46286533 | ||
| Nitric oxide synthase inhibition prevents alveolar bone resorption in experimental periodontitis in rats. | Q46538922 | ||
| Systemic disorders in patients with periodontal disease | Q47975265 | ||
| Gap-junction-mediated communication in human periodontal ligament cells. | Q50990887 | ||
| Comparison of etoricoxib and indomethacin for the treatment of experimental periodontitis in rats. | Q51770324 | ||
| Human periodontal ligament fibroblasts stimulate osteoclastogenesis in response to compression force through TNF-α-mediated activation of CD4+ T cells. | Q54369037 | ||
| Immunohistochemical characteristics of epithelial cell rests of Malassez during cementum repair. | Q54378709 | ||
| P433 | issue | 4 | |
| P921 | main subject | periodontitis | Q520127 |
| osteolysis | Q2035084 | ||
| inflammation | Q101991 | ||
| P304 | page(s) | 442-453 | |
| P577 | publication date | 2014-02-28 | |
| P1433 | published in | Experimental Biology and Medicine | Q15716535 |
| P1476 | title | Infliximab attenuates inflammatory osteolysis in a model of periodontitis in Wistar rats | |
| P478 | volume | 239 |
| Q47232189 | Anti-inflammatory and antiresorptive effects of Calendula officinalis on inflammatory bone loss in rats. |
| Q58552081 | Anti-inflammatory effects of shikonin in human periodontal ligament cells |
| Q40624375 | Chronic Periodontitis Is Associated With Spinal Dysmobility in Patients With Ankylosing Spondylitis |
| Q92406823 | Interleukin-1β is a potential therapeutic target for periodontitis: a narrative review |
| Q49827255 | Periodontitis May Restrain the Mandibular Bone Healing via Disturbing Osteogenic and Osteoclastic Balance |
| Q47948506 | Protective Effect of Infliximab, a Tumor Necrosis Factor-Alfa Inhibitor, on Bleomycin-Induced Lung Fibrosis in Rats. |
| Q54149268 | RANKL Triggers Treg-Mediated Immunoregulation in Inflammatory Osteolysis. |
| Q53031123 | Receptor activator of nuclear factor-κB ligand and sclerostin expression in osteocytes of alveolar bone in rats with ligature-induced periodontitis. |
| Q33843335 | The Effect of Calendula officinalis on Oxidative Stress and Bone Loss in Experimental Periodontitis |
Search more.